Literature DB >> 17413301

Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease.

Paul D Stein1, Afzal Beemath, Frederick A Meyers, Ronald E Olson.   

Abstract

BACKGROUND: Hospitalized patients with exacerbations of chronic obstructive pulmonary disease (COPD), when routinely evaluated for pulmonary embolism (PE), show PE in 25-29% of cases. We assessed the rate of diagnosis of PE and deep venous thrombosis (DVT) in hospitalized patients with COPD and the influence of age on relative risk compared with hospitalized patients who do not have COPD.
METHODS: A retrospective evaluation of data in hospitalized adults with and without COPD from the National Hospital Discharge Survey.
RESULTS: From 1979 to 2003, 58,392,000 adults 20 years of age and older, were hospitalized with COPD in the United States. Among these patients, PE was diagnosed in 381,000 (0.65%) and DVT in 632,000 (1.08%). The relative risk of PE in adults hospitalized with COPD was 1.92 and for DVT it was 1.30. Relative risks were age dependent. Among those aged 20-39 years with COPD, the relative risk of PE was 5.34. Among patients aged 40-59 years, the relative risk of PE decreased to 2.02, and among patients aged 60-79 years the relative risk of PE was 1.23.
CONCLUSION: These data, when compared with the rate of diagnosis of PE in hospitalized patients with exacerbations of COPD, all of whom were evaluated for PE, indicate that PE in patients with COPD is generally underdiagnosed. In young adults, other risk factors in combination with COPD are uncommon, so the contribution of COPD to the risk of PE becomes more apparent than in older patients.

Entities:  

Mesh:

Year:  2007        PMID: 17413301     DOI: 10.2459/01.JCM.0000263509.35573.2c

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  7 in total

1.  Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT.

Authors:  Jonas Jögi; Marie Ekberg; Björn Jonson; Gracijela Bozovic; Marika Bajc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

2.  Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.

Authors:  Stefania Frasson; Gualberto Gussoni; Pierpaolo Di Micco; Raquel Barba; Laurent Bertoletti; Manuel J Nuñez; Beatriz Valero; Angel Luis Samperiz; Agustina Rivas; Manuel Monreal
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

3.  Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study.

Authors:  Stavros G Memtsoudis; Melanie C Besculides; Licia Gaber; Spencer Liu; Alejandro González Della Valle
Journal:  Int Orthop       Date:  2008-10-17       Impact factor: 3.075

4.  Venous thromboembolism in patients with chronic obstructive pulmonary disease.

Authors:  Gregory Piazza; Samuel Z Goldhaber; Aimee Kroll; Robert J Goldberg; Catherine Emery; Frederick A Spencer
Journal:  Am J Med       Date:  2012-08-08       Impact factor: 4.965

5.  Hospitalizations of adults ≥60 years of age with venous thromboembolism.

Authors:  Hussain R Yusuf; Nimia Reyes; Qing C Zhang; Ekwutosi M Okoroh; Azfar-E-Alam Siddiqi; James Tsai
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

6.  A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Kuang-Ming Liao; Hsueh-Yi Lu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  The Incidence of Deep Vein Thrombosis in Asian Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Chung-Yu Chen; Kuang-Ming Liao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.